M.M. Pharma

What M.M. Pharma does

M.M. Pharma is a privately held pharmaceutical contract manufacturer established in 1975 and headquartered in Chennai, Tamil Nadu, India. The company manufactures, supplies, and trades pharmaceutical products including capsules, tablets, soft gelatin capsules, dry syrups, ointments, Ayurvedic preparations, and HFA propellant-based formulations. It operates through a multi-facility footprint with three WHO-GMP certified manufacturing units in Chennai, Puducherry, and Dehradun, employing 1,200+ people and reporting an annual turnover of 400 Crore+ INR. Its go-to-market is sales-led B2B contract manufacturing, primarily serving multinational pharmaceutical companies operating in India and exporting products to international markets via an overseas distribution network. Sub-brands include Landsteiner Cosmetics and Viencee Nutraceuticals, and the company sits within a group of five related operating entities covering pharma, genetic medicines, nutraceuticals, and HFA formulations.

The company's underlying technology is conventional pharmaceutical manufacturing: advanced extraction methods for Ayurvedic capsules and syrups, automatic blister packaging for tablets and capsules, and segregated packaging and quality-testing departments across three ultra-modern factory sites. Quality differentiation is anchored in WHO-GMP certification across all facilities and 45+ years of operational history. The business model is direct B2B contract manufacturing with revenue generated through one-time product sales; pricing is not publicly disclosed and is solicited through a website-based product enquiry system. Distribution is split between domestic direct B2B supply to multinational pharma clients in India and an international distribution network serving multiple overseas nations. The company is family-controlled, led by Managing Director Mr. S. Ramkumar, with no disclosed external institutional, PE, or VC investors.

Name

M.M. Pharma

Legal name

M.M. Pharma

Website

https://mmpharma.org.in

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

11–50 employees

Short description

M.M. Pharma is a privately held Indian pharmaceutical contract manufacturer, founded in 1975 and headquartered in Chennai, operating three WHO-GMP certified facilities that produce capsules, tablets, softgels, ointments, Ayurvedic products, and HFA formulations for multinational pharma clients domestically and internationally.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Contract manufacturing
• Generic formulations
• Ayurvedic medicines
• WHO-GMP certified

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Products Manufacturing and Sales: M.M. Pharma generates revenue through manufacturing and supplying pharmaceutical products including Capsules, Tablets, Softgelatin Capsules, Dry Syrups, Ointments, and Ayurvedic preparations. The company serves both domestic market in India and exports to international markets, with a clientele consisting primarily of multinational pharmaceutical companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

M.M. Pharma manufactures, supplies, and trades pharmaceutical products including pharmaceutical capsules, tablets, softgelatin capsules, dry syrups, ointments, Ayurvedic preparations, and HFA formulations. The company operates three WHO-GMP certified manufacturing facilities in Chennai, Puducherry, and Dehradun, producing across multiple therapeutic categories (cardiac, neuronal, fertility, diabetes, antibiotics, anti-inflammatory, respiratory, gastrointestinal) for multinational pharmaceutical companies in India and international markets.

Product overview

M.M. Pharma is a pharmaceutical manufacturer, supplier, and trader established in 1975, operating as a diversified product portfolio company. The product range spans multiple therapeutic categories including Ointments, Soft Gel (softgelatin capsules), Cardiac, Neuronal, Fertility, Diabetes, Antibiotics, Antibacterial, Analgesis, Anti-Inflammatory, Respiratory, and Gastrointestinal products, along with sub-brands Landsteiner Cosmetics and Viencee Nutraceuticals. The company also manufactures Ayurvedic Capsules and Syrups using advanced extraction methods, and HFA Formulations. Products are produced across three WHO-GMP certified manufacturing facilities in Chennai, Puducherry, and Dehradun, with automated blister packaging for tablets and capsules. The company serves multinational clients in India and international markets.

Differentiator

Problem solved

Functional benefit

Brands

• Landsteiner Cosmetics: Cosmetic products line under the M.M. Pharma group
• Viencee Nutraceuticals
• Viencee Pharma Science
• HFA Formulations

Products and services

• Pharmaceutical Capsules and Tablets Core pharmaceutical products including pharmaceutical capsules, tablets, medicinal capsules, and dry syrups manufactured with compositional accuracy, optimum effectiveness, and longer shelf life for multinational pharmaceutical company clients.
• Softgelatin Capsules (Soft Gel) Softgelatin capsule products manufactured for domestic and international pharmaceutical markets.
• Ointments Pharmaceutical ointments for topical application, manufactured with compositional accuracy and longer shelf life.
• Ayurvedic Capsules and Syrups Ayurvedic formulations including capsules and syrups manufactured using advanced extraction method.
• HFA Formulations HFA (Hydrofluoroalkane) propellant-based pharmaceutical formulations manufactured at WHO-GMP certified facilities in Chennai, Puducherry, and Dehradun.
• Injectable Formulations Injectable pharmaceutical formulations manufactured by the company.
• Viencee Nutraceuticals (Multivitamin and Nutraceuticals) Multivitamin and nutraceutical supplements for health supplementation under the Viencee brand.
• Landsteiner Cosmetics Cosmetic products under the Landsteiner brand marketed by the company.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered minor.

• Applied Communication & ControlsminorOthersGroup company located in Dehradun, Uttarakhand at Khasra No: 122, Selaqui Industrial Area. Part of the M.M. Pharma group of companies.
• CU-V-Kar Genetic Medicines (P) LtdminorOthersGroup company with units in Dehradun (G-63, UPSIDC Industrial Area and Unit-II at Pharmacity, Selaqui). Part of the M.M. Pharma group of companies operating in the pharmaceutical sector.
• Viencee Pharma ScienceminorOthersGroup company with facilities in Kancheepuram and Puducherry. Operates nutraceutical manufacturing unit at Kodithandalam and pharmaceutical manufacturing at Pipdic Electronic Park, Thirubhuvanai, Puducherry.
• PHARMAKminorOthersGroup company located in Chennai at Samson Saroja Street, Golden George Nagar, Nerkundram. Part of the M.M. Pharma group of companies.
• HFA Formulation Private LimitedminorOthersGroup company located in Dehradun at Plot No: E 25 UPSIDC Industrial Area, Selaqui. Also operates a separate website hfaformulation.com and manufactures HFA formulations.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Cipla: One of India's largest pharmaceutical manufacturers with a broad finished dosage form portfolio across respiratory, cardiac, and other therapeutic areas. Comparable to M.M. Pharma on dosage-form breadth and Indian manufacturing footprint, though operating at materially larger scale.
• Sun Pharmaceutical Industries: India's largest pharma company with diversified finished dosage form manufacturing across multiple therapeutic categories and global export reach. Comparable on product breadth, multi-plant Indian footprint, and contract manufacturing for global clients.
• Aurobindo Pharma: Large Indian pharmaceutical manufacturer with extensive finished dosage form and API operations across multiple therapeutic categories. Comparable on dosage-form manufacturing breadth and global export reach, though at significantly larger scale.

Direct peers

• Windlas Biotech: Indian contract development and manufacturing organization (CDMO) producing tablets, capsules, and soft gels for global pharma clients. Directly comparable business model as a contract manufacturer serving multinational customers.
• Strides Pharma Science: Indian pharmaceutical manufacturer producing finished dosage forms (tablets, capsules, soft gels) with focus on regulated markets and contract manufacturing. Comparable on dosage-form portfolio, contract manufacturing model, and international distribution.
• Granules India: Indian pharmaceutical manufacturer focused on finished dosage forms (tablets, capsules, APIs) with strong CMO orientation and global export presence. Closely comparable to M.M. Pharma on dosage-form focus, B2B contract manufacturing model, and export-driven revenue mix.
• Ipca Laboratories: Mid-sized Indian pharmaceutical manufacturer with WHO-GMP facilities producing finished formulations across therapeutic areas and active APIs. Directly comparable on multi-plant Indian manufacturing, WHO-GMP certification, and therapeutic category breadth.
• Ajanta Pharma: Indian specialty pharmaceutical manufacturer with finished dosage form portfolio spanning cardiac, diabetes, and other therapeutic segments, exporting to emerging and developed markets. Comparable on therapeutic breadth, Indian manufacturing footprint, and export focus.
• Marksans Pharma: Indian pharmaceutical manufacturer specializing in finished dosage forms (tablets, capsules, soft gels) for global markets, including contract manufacturing. Comparable on dosage forms, export orientation, and contract manufacturing for international clients.

Emerging players

• Ami Organics: Indian manufacturer specializing in pharmaceutical intermediates and APIs used in finished dosage formulations. Related peer due to overlapping Indian pharma manufacturing infrastructure and supply chain participation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about M.M. Pharma